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Urban–rural and socioeconomic status:
Impact on multimorbidity prevalence
in hospitalized patients
Lynn Robertson1 , Dolapo Ayansina2, Marjorie Johnston1,
Angharad Marks1,3 and Corri Black1,4,5
Abstract
Objective: The aim of this study was to describe multimorbidity prevalence in hospitalized adults, by urban–rural area of
residence and socioeconomic status (SES).
Methods: Linked hospital episode data were used. Adults (18 years) admitted to hospital as an inpatient during 2014 in
Grampian, Scotland, were included. Conditions were identified from admissions during the 5 years prior to the first
admission in 2014. Multimorbidity was defined as 2 conditions and measured using Tonelli et al. based on International
Classification of Diseases-10 coding (preselected list of 30 conditions). We used proportions and 95% confidence intervals
(CIs) to summarize the prevalence of multimorbidity by age group, sex, urban–rural category and deprivation. The
association between multimorbidity and patient characteristics was assessed using the 2 test.
Results: Forty one thousand five hundred and forty-five patients were included (median age 62, 52.6% female). Overall,
27.4% (95% CI 27.0, 27.8) of patients were multimorbid. Multimorbidity prevalence was 28.8% (95% CI 28.1, 29.5) in large
urban versus 22.0% (95% CI 20.9, 23.3) in remote rural areas and 28.7% (95% CI 27.2, 30.3) in the most deprived versus
26.0% (95% CI 25.2, 26.9) in the least deprived areas. This effect was consistent in all age groups, but not statistically
significant in the age group 18–29 years. Multimorbidity increased with age but was similar for males and females.
Conclusion: Given the scarcity of research into the effect of urban–rural area and SES on multimorbidity prevalence
among hospitalized patients, these findings should inform future research into new models of care, including the con-
sideration of urban–rural area and SES.
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Introduction
Multimorbidity, defined as the coexistence of two or more
conditions in the same individual,1,2 is common and
increasing.3–5 Recent policy publications have highlighted
multimorbidity as a growing public health concern and a
key research priority at the international level.2,6,7 Multi-
morbidity places a burden on patients, their caregivers and
health systems.2 As highlighted by the World Health
Organization, patients with multimorbidity are at higher
risk of safety issues including polypharmacy, complex
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management regimens and more frequent and complex
interactions with healthcare services.8
The Academy of Medical Sciences recently highlighted
that the health systems are largely configured for individual
diseases rather than multimorbidity and suggested that this
is likely to be a barrier to the provision of integrated
care required by patients with multimorbidity.2 A
person-centred approach for people with multimorbidity
has been recommended, including developing models of
care and designing secondary care around those with
multimorbidity.6,7,9 The National Institute for Health
and Care Excellence has also recommended taking account
of multimorbidity in tailoring the approach to care.10
People with multimorbidity have more hospital admis-
sions, stay longer in hospital, are more likely to be readmitted
and have a higher risk of mortality than individuals without
multimorbidity.7,11 Patients with multimorbidity may be dis-
charged from hospital with ongoing care needs, which can
have an impact on their families and carers.12 Identifying
patients with multimorbidity at the point of admission has the
potential for facilitating more informed care, taking account
of the management of multiple conditions. Discharge plan-
ning ideally starts at the point of admission,13,14 and consid-
eration of multimorbidity is an important part of this
process.10 With the growing availability of electronic health
records, there is now the potential to identify patients with
multimorbidity at the point of admissionbyusing information
about their prior admission history, thus supporting a tailored,
person-centred approach to decision-making and secondary
care planning. In the absence of integrated health records in
Scotland (including primary and secondary care data), the
most readily available source of information at the point of
admission is prior hospital admissions.
Socio-demographic factors influence health and well-
being. Socioeconomic deprivation is an important determi-
nant of poor health outcomes and lower life expectancy.15
Rural residency is associated with poor outcomes in several
health conditions16 but also associated with higher life
expectancy in Scotland.17 The social-ecological model
views any differences in health and well-being as the out-
come of interaction among many factors at different levels
– the individual, interpersonal, community, organizational
and policy/enabling environment,18 as has been demon-
strated in, for example, cancer outcomes.19
Multimorbidity is associated with age, socioeconomic
status (SES), and there have been reports of urban–rural
divides in the prevalence of multimorbidity.2,20 This evi-
dence, however, comes from primary care and general pop-
ulation studies. Our literature search for studies reporting
the prevalence of multimorbidity in hospitalized patients
revealed that the majority of studies have been focussed on
adults over 65 years and/or patients with high severity of
illness or highly selected patients.21–30 Studies including
unselected younger patients have reported the overall pre-
valence of multimorbidity,31–34 but less often in detail by
gender or specific age groups,32,33 and we did not identify
any studies investigating the prevalence of multimorbidity
by urban–rural area or SES. In Scotland, rurality and SES
are taken into account for allocating resources to NHS
Boards.35 It is important therefore to understand and
demonstrate the burden of multimorbidity in different
socioeconomic and geographical groups, to help ensure
these formulas take account of any variances. Our previous
study compared two multimorbidity measures for assessing
the prevalence and outcomes of multimorbidity.11 In this
study, the aim was to describe the prevalence of multimor-
bidity by urban–rural area and SES.
Methods
Study design and setting
This study is reported as per REporting of studies Con-
ducted using Observational Routinely-collected Data
(RECORD) guidelines.36 This was a population-based
observational study using linked electronic health records
carried out in a secondary care setting in a single health
region in north-east Scotland (Grampian region, total pop-
ulation 2014, 584,22037). Aberdeen is the largest city in the
region with a total population of 113,477.37 The region is
spread over approximately 3000 square miles of city, town,
village and rural communities.38 The population is served
by one tertiary hospital in Aberdeen, specialist hospitals
(children’s, maternity, mental health, palliative care and
care of the elderly), and one district general hospital. There
are also several community hospitals where most patients
are cared for by their own general practitioners (GPs). The
age, sex, socioeconomic and urban–rural distribution of the
Grampian population is presented in Table 1.
Data sources
We used hospital episode data, Scottish Morbidity Record
(SMR),41 from general/acute (SMR01) and psychiatric
(SMR04) admissions, from the years 2009 to 2014. SMR
is an episode-based patient record relating to all patients
discharged from the hospital in Scotland. A record is gen-
erated when a patient completes an episode of care (period
of time spent under the care of one consultant). These
episodes are then linked to form a continuous inpatient stay
representing one admission, which may include transfers
between consultants, specialties and/or hospitals. SMR data
are collated in a national database, managed by Information
Services Division Scotland,42 and data are returned to each
regional health authority on an ongoing basis. Data col-
lected include patient identifiable and demographic details,
episode management details, general clinical information
and death data. Clinical information is recorded as the main
diagnosis and up to five other significant diagnoses and
coded using the World Health Organization’s International
Classification of Diseases (ICD-10). Using hospital episode
data reflects the real-world situation at the point of
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admission. In the absence of integrated patient records,
hospital episode data may be the only information available
to clinicians when a patient is admitted.
Study population
We included all adult patients (18 years) admitted to all
hospitals as an inpatient during 2014 (general/acute admis-
sions only), in a single regional health authority (NHS
Grampian). A patient’s first admission in 2014 was classi-
fied as their ‘index admission’, and the admission date was
classified as their ‘index date’. We excluded day case,
obstetric and psychiatric admissions when identifying the
index admission/study population. The flow diagram for
identifying the study population is shown in Figure 1.
Multimorbidity
Multimorbidity was defined a priori as 2 conditions,1,10
measured using an unweighted simple count of conditions.
Conditions were identified from general/acute (SMR01,
including day cases) and psychiatric (SMR04) admissions
in the 5 years prior to the index date. All ICD-10 codes
recorded as main or other diagnoses (up to five) were
included. We used the multimorbidity measure developed
by Tonelli et al.43 This measure was based on the measure
developed in the study by Barnett et al.20 for measuring
multimorbidity in a primary care population, using coding
unique to primary care in the United Kingdom (Read
codes). Tonelli et al.43 developed a corresponding validated
coding scheme for use with administrative data based on
the ICD system. The specific ICD-10 codes for the 30
conditions included are detailed in Online Appendix 1.
These codes were translated into computerized algorithms
and applied to SMR data to identify the conditions of inter-
est. For data quality purposes, a validation data set contain-
ing all ICD-10 codes for main and other diagnoses recorded
in the 5 years prior to the index date for a random sample of
50 patients were manually checked against the final data
set. This showed that the computerized algorithms cor-
rectly captured conditions for all patients in the sample.
Urban–rural and SES measures
Urban–rural status was measured using the Scottish Govern-
ment 6-fold Urban Rural Classification 2009/10.39 This clas-
sification is based on two main criteria – settlement size and
drive time to major settlements based on postcodes. The 6-
fold Urban Rural Classification categories are as follows:
1. Large urban areas – settlements of 125,000
people;
2. Other urban areas – settlements of 10,000–124,999
people;
SIMD
(missing=314)
SMR04
psychiatric
SMR01
general/acute
Admissions in 2014
Inpatient general/acute
n = 48,115 patients
Excluded:
Age <18 years
n = 6,570
Study populationa
n = 41,545 patients
Linkage
Urban-Rural
(missing=576)
Grampian population
Figure 1. Flowchart of study population and data linkage. aCHI number was missing or invalid for 662 inpatient general/acute
admissions in 2014 (patients 18 years), therefore not included in the study population. SMR: Scottish Morbidity Record; SIMD:
Scottish Index of Multiple Deprivation; CHI: Community Health Index.
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3. Accessible small towns – settlements of 3000–9999
people, and within a 30 min drive time of a settle-
ment of 10,000;
4. Remote small towns – settlements of 3000–9999
people, and with a drive time of over 30 min to a
settlement of 10,000;
5. Accessible rural – areas with a population of <3000
people, and within a 30 min drive time of a settle-
ment of 10,000;
6. Remote rural – areas with a population of <3000
people, and with a drive time of over 30 min to a
settlement of 10,000.
SES was measured using the Scottish Index of Multiple
Deprivation (SIMD) 2012, categorized as quintiles (quin-
tile 1 is the most deprived and quintile 5 the least
deprived).40 SIMD provides a deprivation rank for each
of the 6505 data zones in Scotland, based on postcodes.
SIMD combines seven domains of deprivation, namely,
income, employment, health, education, skills and train-
ing, housing, geographic access and crime. The Scottish
Government provides an overview of the SIMD metho-
dology.44 Patients’ SIMD quintile was identified by link-
ing their postcode to the Scottish Government SIMD
lookup files.
Other covariates
Other baseline characteristics were sex, age and admission
type (routine or emergency). Age was categorized into six
age groups.
Data linkage
NHS Grampian SMR data were held in a dedicated
secure server, managed by the accredited Grampian
Data Safe Haven (DaSH).45 The Community Health
Index (CHI) number, a unique patient identifier used
throughout the Scottish healthcare system, was used to
link the study population to hospital episode data using
deterministic matching. Postcodes were used to link the
study population to the Urban Rural Classification and
SIMD to identify categories using the Scottish Govern-
ment’s lookup files. The de-identified data set was pre-
pared and hosted by the Grampian DaSH,45 allowing
secure controlled access for researchers while ensuring
data security.
There were 662 admissions with missing CHI numbers
in 2014 (inpatient general/acute, 18 years), therefore
these were not included in our study population. There
were 314 patients who could not be linked with SIMD, and
576 patients who could not be linked with Urban Rural
Classification, because of postcode issues (Figure 1). The
characteristics of patients with missing values are reported
in Online Appendix 2.
Statistical analysis
Baseline characteristics were described as frequencies and
percentages or as median and interquartile range (IQR). We
calculated the prevalence of multimorbidity, and 95% con-
fidence intervals (CIs), as the proportion of patients with
2 conditions. Multimorbidity prevalence was reported by
age group, sex, admission type, Urban Rural category and
SIMD quintile. To assess the association between multi-
morbidity status (<2 or 2 conditions) and patient charac-
teristics, we used the 2 test (2  n tables). Analyses were
performed using Stata v13.0.
Ethical approval
The study was approved by the North of Scotland Research
Ethics Service (REC B Ref. 16/NI/0088), NHS Grampian
Research and Development (Ref. 2016UA006) and NHS
Grampian Caldicott Guardian. The DaSH registration num-
ber (DaSH 140) provides provenance for all data sets and
linkage processes.
Results
Characteristics of study population
Table 1 shows the characteristics of the study population.
There were 41,545 patients, with a median age of 62 years
(IQR 44–75 years) and 52.6%were female. The majority of
patients were admitted as an emergency (69.3%). Just over
half of patients were from the two urban categories (52.7%)
and the two least deprived quintiles (52.4%). Just over a
third (35.5%) of patients had no admission to hospital in the
5 years prior to the index date. The distribution of urban–
rural and SIMD categories for patients who had no admis-
sion in the previous 5 years was very similar to the overall
study population.
Comparing the study (hospitalized) population with the
general population (Table 1), there was a higher propor-
tion of patients from deprived areas and a lower propor-
tion of patients from less deprived areas than in the
general population. There was a higher proportion of
patients from remote areas than in the general population,
while the proportion of patients from accessible small
towns and accessible rural areas was slightly lower than
the general population.
Prevalence of multimorbidity
Of the 30 individual conditions that contributed to the
Tonelli measure, the most common conditions recorded
were hypertension (19.0%), diabetes (8.4%), chronic kid-
ney disease (8.2%), asthma (6.7%) and atrial fibrillation
and flutter (6.1%) (Online Appendix 1). Counts of condi-
tions ranged from 0 to 11 (Table 2).
Table 1 shows the prevalence of multimorbidity (2
conditions) by baseline characteristics. The overall
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prevalence of multimorbidity was 27.4% (95% CI 27.0,
27.8). There was a significant association between multi-
morbidity status and urban–rural category. The prevalence
of multimorbidity was higher in patients from urban areas
compared to rural areas (28.8% (95% CI 28.1, 29.5) in large
urban versus 22.0% (95% CI 20.9, 23.3) in remote rural).
This effect was consistent in all age groups, but not statis-
tically significant in the age group 18–29 years (Figure 2
and Online Appendix 3).
There was a significant association between multi-
morbidity status and SIMD quintile. The prevalence of
multimorbidity was higher in patients from more
deprived areas compared to less deprived (28.7% (95%
CI 27.2, 30.3) in the most deprived quintile versus
26.0% (95% CI 25.2, 26.9) in the least deprived quin-
tile). This effect was consistent in all age groups, but not
statistically significant in the age group 18–29 years
(Figure 3 and Online Appendix 4).
The proportion of patients with multimorbidity
increased with age. Figure 4 shows the number of condi-
tions cumulatively by 5-year age bands. By the age of 55–
59 years, 22.5% of patients were multimorbid, and by age
65–69 years, approximately one-third of patients were mul-
timorbid. In absolute terms, more people with multimor-
bidity were 60 years and older (n ¼ 8809, 77.3%) than
younger than 60 years (n ¼ 2580, 22.6%). There was no
association between multimorbidity status and gender.
Discussion
Main findings
To our knowledge, we are the first to characterize multi-
morbidity by urban–rural area and SES in a hospitalized
population which also included younger adults. We found
that multimorbidity was more common among patients
from urban areas and those from more deprived areas.
Multimorbidity prevalence was higher in patients from
urban areas compared to other areas, in all age groups,
although not statistically significant in the youngest age
group. Although our search did not identify any studies
in hospitalized patients investigating multimorbidity by
urban–rural area, primary care and general population stud-
ies have reported multimorbidity to be higher in urban
areas46 or similar for urban and rural.47,48 The effect of
urban–rural environments on health is affected by a number
of factors which operate together, making the interpretation
of our findings complex. The social-ecological model
encourages us to consider the complexity of determining
mechanisms, both individual and environmental that affect
health and well-being. For example, patient-level health-
seeking behaviours, healthcare providers’ behaviours and
access to services may operate differently in urban and
rural areas, as has been demonstrated in cancer outcomes.19
Interpretation of the urban–rural findings must involve
consideration of how multimorbidity was measured. Only
those patients who had a previous hospital admission will
have conditions recorded. Therefore, there will be some
patients classified as not multimorbid, who have multimor-
bidity, but have been managed in primary care and not
previously admitted to hospital. Our population, therefore,
represents those whose health conditions were serious
enough to require admission to hospital, and this may affect
the urban–rural disparity in multimorbidity prevalence.
The finding that multimorbidity was more common in
patients from deprived areas has been consistently reported
in primary care and general population studies.2 We found
this effect in all age groups, although not statistically sig-
nificant in the youngest age group. A Scottish primary care
study reported similar results, except that they did not find
this effect maintained in the oldest age group (85
years).20 This might be explained by the fact that the oldest
patients in a hospitalized population are likely to be in
poorer health than the oldest patients in a primary care
population (which will include healthy survivors). In fact,
our oldest age group (90 years) showed the widest gap in
multimorbidity prevalence between patients from the most
and least deprived areas. Factors influencing the associa-
tion between SES and health are numerous and complex
and would include similar factors as mentioned above in
relation to urban–rural status.
We found an overall multimorbidity prevalence rate of
27.4%. Previous studies of unselected adult hospitalized
patients have reported a range of prevalence rates (24–
78%).31–34 These studies measured multimorbidity in dif-
ferent ways which makes comparison difficult. It has been
highlighted that varying approaches to defining and mea-
suring multimorbidity complicate the comparison and
synthesis of research findings.2,49
We found that the prevalence of multimorbidity
increased with age, a well-established association.2,3,33
Nevertheless, there was still multimorbidity present in
younger patients. Clinically, there will be greater pressure
on secondary care as a result of increasing multimorbidity,
and younger patients with multimorbidity will have greater
Table 2. Number and per cent of patients with different counts
of conditions.
Number of conditionsa Number of patients (%)
0 22,884b (55.1)
1 7272 (17.5)
2 5173 (12.5)
3 3241 (7.8)
4 1665 (4.0)
5 783 (1.9)
6 357 (0.9)
7 100 (0.2)
8 56 (0.1)
9 14 (0.0)
aCounts of 10 and 11 suppressed due to low numbers.
bIncludes 14,765 patients who had no admission in the 5 years prior to
index date.
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healthcare needs earlier in their lives, will live with multi-
morbidity for longer and will have the prospect of accumu-
lating more conditions over time.
This was a large, population-based study. We ascer-
tained conditions over the 5 years prior to the index date,
as longer lookback periods are more effective for identify-
ing conditions,50,51 and used validated coding algorithms.
We used high-quality administrative data52 and undertook
quality assurance assessments to ensure the accuracy of
coding algorithms. The methodology used in our study
would be applicable to health systems worldwide that use
the ICD-10 coding system. Although our study was limited
to a single geographical area, the findings would likely
apply to other hospitalized populations with similar char-
acteristics to our study population.
Limitations, however, should be recognized. Conditions
were identified from hospital episode data in the 5 years
prior to admission in 2014, and 35.5% of our population
had no admission in the previous 5 years. Those with no
admission, however, were similarly distributed by urban–
rural and SIMD category as the study population as a
whole. Nonetheless, we will not have recorded conditions
for patients who were first-time presenters and will
have underestimated the multimorbidity burden in our
population, especially for conditions that do not lead to
hospitalization or which are not a priority for recording
on discharge records. However, as hospital episode data
may be the only information available to clinicians when
a patient is admitted, we feel that using this methodology is
relevant and important to examine. We have not fully
adjusted for all confounding factors as our aim was to
describe the burden of multimorbidity, rather than identify
significant risk factors or adjusted associations. In addition,
there are complex interrelationships between multimorbid-
ity, urban–rural and SES measures, for example, SIMD has
domains for health and geographical access, and further
detailed examination of these complex relationships would
be useful in future research. Finally, as there is no universal
‘gold standard’ multimorbidity measure,1 we used the list
of conditions from Tonelli et al. which provided validated
ICD-10 coding schemes, acknowledging that there are lim-
itations in the application of ICD-10 codes. For example, a
study comparing two multimorbidity measures reported
that while 12 conditions were common to both measures,
only 3 of these had identical ICD-10 codes.11 All coding
can be affected by variation in coding practices. In Scotland
for instance, guidelines are provided regarding the coding
of comorbidities, in which a list of comorbidity groups are
Urban-Rural
category
Age group
18-29 30-44* 45-59* 60-74* 75-89* ≥90*
1 Large urban 5.3% 12.2% 22.1% 36.0% 49.2% 57.1%
2 6.4% 12.0% 18.9% 35.0% 47.2% 50.0%
3 8.5% 9.7% 17.4% 34.5% 43.3% 52.5%
4 7.1% 11.8% 17.5% 32.4% 44.0% 41.4%
5 6.9% 9.7% 18.3% 30.4% 45.5% 47.1%
6 Remote rural 3.7% 7.8% 13.1% 25.9% 36.5% 38.5%
5.3
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Figure 2. Prevalence of multimorbidity by age and urban–rural category. *p < 0.05 (2 test for association between multimorbidity
status (<2 or 2 conditions) and urban–rural category).
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SIMD 
quintile
Age group
18-29 30-44* 45-59* 60-74* 75-89* ≥90*
1 5.8% 13.6% 27.5% 38.3% 51.0% 72.2%
2 7.3% 12.8% 22.3% 35.9% 50.4% 46.9%
3 6.0% 11.1% 19.7% 34.4% 46.6% 50.0%
4 6.1% 11.1% 17.1% 30.5% 43.9% 47.1%
5 4.8% 8.9% 15.7% 31.2% 43.5% 51.9%
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Figure 3. Prevalence of multimorbidity by age and socioeconomic status. SIMD: Scottish Index of Multiple Deprivation. *p < 0.05 (2
test for association between multimorbidity status (<2 or 2 conditions) and SIMD quintiles).
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prioritized as important conditions to record.53 Nevertheless,
ICD-10 is a well-known coding system used worldwide.
The urban–rural disparities in multimorbidity preva-
lence require further investigation into the mechanisms
behind this association. Studies should be carefully and
appropriately designed taking account of the complex inter-
relationships between urban–rural and SES measures, and
the potential of electronic health data provides opportuni-
ties to do that. Information from primary care, secondary
care and social care will be required to fully explain the
complexities and highlight avoidable inequalities. The
importance of an integrated primary and secondary care
patient record is therefore highlighted.
Importantly for healthcare planners and policymakers,
the findings of our study support calls for new models of
care for patients with multimorbidity and designing sec-
ondary care around those with multimorbidity, since we
have demonstrated the high burden of multimorbidity in a
hospitalized population.7,54 Any action to improve care and
outcomes for people with multimorbidity should not be
restricted to services targeting elderly people,7 and there
should be ongoing consideration of the link between multi-
morbidity and wider social determinants of health.
Conclusions
Given the scarcity of research into the effect of urban–rural
area and SES on the prevalence of multimorbidity among
hospitalized patients, in particular, including younger
patients, these findings should inform future research into
new models of care, including the consideration of urban–
rural area and SES.
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